Skip to main content

History and Epidemiology

  • Chapter
  • First Online:

Abstract

In December of 2019, a cluster of cases of atypical pneumonia in Wuhan China caught the attention of infectious disease investigators in China. In a short span of time, more cases emerged without any identifiable source. Genetic sequencing identified the culprit pathogen as that of a novel coronavirus. The virus was named SARS-CoV-2, and within 100 days, that virus had spread across the globe causing a pandemic of proportions that were unprecedented in modern times. The novel coronavirus is genetically similar to two other coronaviruses responsible for large outbreaks: SARS-CoV, responsible for the Severe Acute Respiratory Syndrome outbreak of 2002, and MERS-CoV, responsible for the 2012 outbreak of Middle East Respiratory Syndrome. The clinical criteria for SARS-CoV-2 infection are acute onset of fever and cough or any three of the following: fever, cough, general weakness/fatigue, headache, myalgia, sore throat, coryza, dyspnea, anorexia/nausea/vomiting, diarrhea, or altered mental status. Transmission of the virus occurs primarily by person-to-person contact with droplet particles. Though contact tracing has proven difficult due to a number of asymptomatic carriers, control of the spread has also been complicated by the emergence of a number of variants. As the status of the pandemic evolves, it is clear that controlling the spread of the virus is going to rely on the ongoing coordinated efforts of scientists, healthcare professionals, and animal researchers across the globe.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Meo SA, Alkowikan AM, Al-Khlaiwai Meo IM, Halepoto DM, Igbal M, Usmani AM, Hajjar W, Ahmed N (2020) Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. Eur Rev Med Pharmacol Sci 24:2012–2019

    CAS  PubMed  Google Scholar 

  2. Muralidar S, Ambi S, Sekaran S, Krishnan U (2020) The Emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response, and potential therapeutic targets of SARS-COV2. Biochemie 179:85–100

    Article  CAS  Google Scholar 

  3. World Health Organization (2020, January 12) COVID-19 China. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233

  4. World Health Organization (2020) Laboratory testing for SARS-CoV-2: Interim guidelines. WHO/2019-nCoV/laboratory/2020.6

    Google Scholar 

  5. Liu Q, Xu K, Wang X, Wang W (2020) From SARS to COVID-19: what lessons have we learned? J Infect Public Health 13:1611–1618

    Article  Google Scholar 

  6. World Health Organization (ed) (2016) International Health Regulations (2005), 3rd edn. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/246107

    Google Scholar 

  7. World Health Organization (2000, January 30) Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of the novel coronavirus (2019-nCoV). https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)

  8. Halaji M, Farahani A, Ranjbar R, Heiat M, Dehkordi FS (2020) Emerging coronaviruses: first SARS, second MERS and third SARS-CoV2. Epidemiological updates of Covid 19. Infez Med Suppl 1:6–17

    Google Scholar 

  9. World Health Organization (2020, March 11) WHO Director-General’s opening remarks at the media briefing on COVID-19. WHO Directhttps: //www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020or-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020

  10. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O’Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH, mRNA-1273 Study Group (2020) An mRNA Vaccine against SARS-CoV-2 - preliminary report. N Engl J Med 383(20):1920–1931. https://doi.org/10.1056/NEJMoa2022483

    Article  CAS  PubMed  Google Scholar 

  11. World Health Organization (2020) Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief, 15 May 2020. World Health Organization. https://apps.who.int/iris/handle/10665/332095. License: CC BY-NC-SA 3.0 IGO

  12. World Health Organization (2020) COVID-19 pandemic: countries urged to take stronger action to stop spread of harmful information, 23 September 2020. https://www.who.int/news/item/23-09-2020-covid-19-pandemic-countries-urged-to-take-stronger-action-to-stop-spread-of-harmful-information

  13. Food and Drug Administration (2021) FDA News Release: FDA Approves First COVID-19 Vaccine. 2021, August 23. FDA Approves First COVID https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine-19 Vaccine | FDA

  14. Peeri N, Shresta N, Rahman MS, Zaki R, Tan Z, Bibi S, Baghbanzadeh M, Aghamohammed N, Zhang W, Haque U (2020) The SARS, MERS, and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? Int J Epidemiol. 49(3):717–726

    Article  Google Scholar 

  15. Hui D, Zumla A (2019) Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin N Am 33(4):869–889. https://doi.org/10.1016/j.idc.2019.07.001

    Article  Google Scholar 

  16. Zumla A, Hui DS, Perlman S (2015) Middle East respiratory syndrome. Lancet (London, England) 386(9997):995–1007. https://doi.org/10.1016/S0140-6736(15)60454-8

    Article  Google Scholar 

  17. Rahman S, Montero M, Rowe K, Kirton R, Kunik F Jr (2021) Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence. Expert Rev Clin Pharmacol 14(5):601–621. https://doi.org/10.1080/17512433.2021.1902303

    Article  CAS  PubMed  Google Scholar 

  18. Zhang X, Huang HJ, Zhuang DL, Nasser M, Yang M, Yang M, Zhu P, Zhao M (2020) Biological, clinical, and epidemiological features of COVID-19, SARS, and MERS and AutoDock simulation of ACE2. Infect Dis Poverty 9:99

    Article  CAS  Google Scholar 

  19. Friend T, Stebbing J (2021) What is the intermediate host species of SARS-CoV-2? Futur Virol. https://doi.org/10.2217/fvl-2020-0390

  20. Prince T, Smith SL, Radford AD, Solomon T, Hughes GL, Patterson EI (2021) SARS-CoV-2 infections in animals: reservoirs for reverse zoonosis and models for study. Viruses. 13(3):494. https://doi.org/10.3390/v13030494. PMID: 33802857; PMCID: PMC8002747

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. The World Health Organization (2020) WHO-convened Global Study of Origins of SARS-CoV-2: China Part. 2021, April, 6. https://www.who.int/publications/i/item/who-convened-global-study-of-origins-of-sars-cov-2-china-part

  22. World Health Organization (2021) Guidance for the surveillance of SARS-CoV-2 variants: Interim Guidance. 2021, August 9. https://www.who.int/publications/i/item/WHO_2019-nCoV_surveillance_variants

  23. World Health Organization (2021) Tracking SARS-CoV-2 Variants. 2021, October 29. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/

  24. Walensky RP, Walke HT, Fauci AS (2021) SARS-CoV-2 variants of concern in the United States—challenges and opportunities. JAMA 325(11):1037–1038. https://doi.org/10.1001/jama.2021.2294

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Teyssou E, Delagrèverie H, Visseaux B, Lambert-Niclot S, Brichler S, Ferre V, Marot S, Jary A, Todesco E, Schnuriger A, Ghidaoui E, Abdi B, Akhavan S, Houhou-Fidouh N, Charpentier C, Morand-Joubert L, Boutolleau D, Descamps D, Calvez V, Marcelin AG, Soulie C (2021) The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect 83(4):e1–e3. https://doi.org/10.1016/j.jinf.2021.08.027

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Tian D, Sun Y, Zhou J, Ye Q (2021) The global epidemic of SARS-CoV-2 variants and their mutational immune escape. J Med Virol. https://doi.org/10.1002/jmv.27376. Advance online publication

  27. Burki T (2021) Understanding variants of SARS-CoV-2. Lancet (London, England) 397(10273):462. https://doi.org/10.1016/S0140-6736(21)00298-1

    Article  CAS  Google Scholar 

  28. Boehm E, Kronig I, Neher RA, Eckerle I, Vetter P, Kaiser L, Geneva Centre for Emerging Viral Diseases (2021) Novel SARS-CoV-2 variants: the pandemics within the pandemic. Clin Microbiol Infect 27(8):1109–1117. https://doi.org/10.1016/j.cmi.2021.05.022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Choi JY, Smith DM (2021) SARS-CoV-2 variants of concern. Yonsei Med J 62(11):961–968. https://doi.org/10.3349/ymj.2021.62.11.961

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Jogalekar MP, Veerabathini A, Gangadaran P (2021) SARS-CoV-2 variants: a double-edged sword? Exp Biol Med (Maywood, NJ) 246(15):1721–1726. https://doi.org/10.1177/15353702211014146

    Article  CAS  Google Scholar 

  31. Li M, Lou F, Fan H (2021) SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19. Signal Transduct Target Ther 6(1):349. https://doi.org/10.1038/s41392-021-00767-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. The World Health Organization (2020) Public Health Surveillance for COVID-19: Interim Guidance. 2020, December 16. https://www.who.int/publications/i/item/who-2019-nCoV-surveillanceguidance-2020.7

  33. Locatelli I, Trächsel B, Rousson V (2021) Estimating the basic reproduction number for COVID-19 in Western Europe. PLoS One 16(3):e0248731. https://doi.org/10.1371/journal.pone.0248731

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Li H, Burm Sw, Hong SW, Ghayda RA, Kronbichler A, Smith L, Koyanagi A, Jacob L, Lee KH, Shin JI (2021) A comprehensive review of coronavirus disease 2019: epidemiology, transmission, risk factors, and international responses. Yonsei Med J 62(1):1–11

    Article  Google Scholar 

  35. Delamater PL, Street EJ, Leslie TF, Yang Y, Jacobsen KH (2019) Complexity of the basic reproduction number (R0). Emerg Infect Dis 25(1):1–4. https://doi.org/10.3201/eid2501.171901

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ke R, Romero-Severson E, Sanche S, Hengartner N (2021) Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination. J Theor Biol 517:110621. https://doi.org/10.1016/j.jtbi.2021.110621

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Riou J, Althaus CL (2020) Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 25(4):2000058. https://doi.org/10.2807/1560-7917.ES.2020.25.4.2000058

    Article  PubMed Central  Google Scholar 

  38. Xiao X, Newman C, Buesching CD et al (2021) Animal sales from Wuhan wet markets immediately prior to the COVID-19 pandemic. Sci Rep 11:11898. https://doi.org/10.1038/s41598-021-91470-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sharun K, Dhama K, Pawde AM, Gortázar C, Tiwari R, Bonilla-Aldana DK, Rodriguez-Morales AJ, de la Fuente J, Michalak I, Attia YA (2021) SARS-CoV-2 in animals: potential for unknown reservoir hosts and public health implications. Vet Q 41(1):181–201. https://doi.org/10.1080/01652176.2021.1921311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Oreshkova N, Molenaar RJ, Vreman S, Harders F, Oude Munnink BB, Hakze-van der Honing RW, Gerhards N, Tolsma P, Bouwstra R, Sikkema RS, Tacken MG, de Rooij MM, Weesendorp E, Engelsma MY, Bruschke CJ, Smit LA, Koopmans M, van der Poel WH, Stegeman A (2020) SARS-CoV-2 infection in farmed minks, the Netherlands, April and May 2020. Euro Surveill. 25(23):2001005. https://doi.org/10.2807/1560-7917.ES.2020.25.23.2001005

    Article  PubMed Central  Google Scholar 

  41. Tiwari R, Dhama K, Sharun K, Iqbal Yatoo M, Malik YS, Singh R, Michalak I, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020) COVID-19: animals, veterinary and zoonotic links. Vet Q 40(1):169–182. https://doi.org/10.1080/01652176.2020.1766725

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Shi J, Wen Z, Zhong G, Yang H, Wang C, Huang B, Liu R, He X, Shuai L, Sun Z, Zhao Y, Liu P, Liang L, Cui P, Wang J, Zhang X, Guan Y, Tan W, Wu G, Chen H, Bu Z (2020) Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science. 368(6494):1016–1020. https://doi.org/10.1126/science.abb7015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Salian VS, Wright JA, Vedell PT, Nair S, Li C, Kandimalla M, Tang X, Carmona Porquera EM, Kalari KR, Kandimalla KK (2021) COVID-19 transmission, current treatment, and future therapeutic strategies. Mol Pharm 18(3):754–771. https://doi.org/10.1021/acs.molpharmaceut.0c00608

    Article  CAS  PubMed  Google Scholar 

  44. The World Health Organization (2020) Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations. 2020, March 29. https://www.who.int/news-room/commentaries/detail/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations

  45. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC (2020) Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 324(8):782–793. https://doi.org/10.1001/jama.2020.12839

    Article  CAS  PubMed  Google Scholar 

  46. Mendes Correa MC, Leal FE, Villas Boas LS, Witkin SS, de Paula A, Tozetto Mendonza TR, Ferreira NE, Curty G, de Carvalho PS, Buss LF, Costa SF, da Cunha Carvalho FM, Kawakami J, Taniwaki NN, Paiao H, da Silva Bizário JC, de Jesus JG, Sabino EC, Romano CM, Grepan R, Sesso A (2021) Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: a report of two cases. J Med Virol 93(9):5603–5607. https://doi.org/10.1002/jmv.27021

    Article  CAS  PubMed  Google Scholar 

  47. Lutgring JD, Tobolowsky FA, Hatfield KM, Lehnertz NB, Sullivan MM, Martin KG, Keaton A, Sexton DJ, Tamin A, Harcourt JL, Thornburg NJ, Reddy SC, Jernigan JA (2021) Evaluating the presence of replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from nursing home residents with persistently positive reverse transcription polymerase chain reaction (RT-PCR) results. Clin Infect Dis. 2021:ciab436. https://doi.org/10.1093/cid/ciab436

    Article  CAS  Google Scholar 

  48. Johansson MA, Quandelacy TM, Kada S, Prasad PV, Steele M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC (2021) SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open 4(1):e2035057. https://doi.org/10.1001/jamanetworkopen.2020.35057

    Article  PubMed  PubMed Central  Google Scholar 

  49. Tong ZD, Tang A, Li KF, Li P, Wang HL, Yi JP, Zhang YL, Yan JB (2020) Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerg Infect Dis 26(5):1052–1054. https://doi.org/10.3201/eid2605.200198

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Chaw L, Koh WC, Jamaludin SA, Naing L, Alikhan MF, Wong J (2020) Analysis of SARS-CoV-2 transmission in different settings, Brunei. Emerg Infect Dis 26(11):2598–2606. https://doi.org/10.3201/eid2611.202263

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Behforouz A, Ferdosian F, Bahrami R (2020) Vertical transmission of coronavirus disease 19 (COVID-19) from infected pregnant mothers to neonates: a review. Fetal Pediatr Pathol 39(3):246–250. https://doi.org/10.1080/15513815.2020.1747120

    Article  PubMed  Google Scholar 

  52. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, Benachi A, De Luca D (2020) Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11(1):3572. https://doi.org/10.1038/s41467-020-17436-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Li M, Chen L, Zhang J, Xiong C, Li X (2020) The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 15(4):e0230295. https://doi.org/10.1371/journal.pone.0230295

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Chaubey I, Vignesh R, Babu H, Wagoner I, Govindaraj S, Velu V (2021) SARS-CoV-2 in pregnant women: consequences of vertical transmission. Front Cell Infect Microbiol 11:717104. https://doi.org/10.3389/fcimb.2021.717104

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Walker KF, O'Donoghue K, Grace N, Dorling J, Comeau JL, Li W, Thornton JG (2020) Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG 127(11):1324–1336. https://doi.org/10.1111/1471-0528.16362

    Article  CAS  PubMed  Google Scholar 

  56. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J, Yang H, Hou W, Zhang Y (2020) Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet (London, England) 395(10226):809–815. https://doi.org/10.1016/S0140-6736(20)30360-3

    Article  CAS  Google Scholar 

  57. Alzamora MC, Paredes T, Caceres D, Webb CM, Valdez LM, La Rosa M (2020) Severe COVID-19 during pregnancy and possible vertical transmission. Am J Perinatol 37(8):861–865. https://doi.org/10.1055/s-0040-1710050

    Article  PubMed  PubMed Central  Google Scholar 

  58. Salem D, Katranji F, Bakdash T (2021) COVID-19 infection in pregnant women: review of maternal and fetal outcomes. Int J Gynaecol Obstet 152(3):291–298

    Article  CAS  Google Scholar 

  59. Schwartz DA, Graham AL (2020) Potential maternal and infant outcomes from (Wuhan) coronavirus 2019-nCoV infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 12(2):194. https://doi.org/10.3390/v12020194

    Article  PubMed Central  Google Scholar 

  60. Moore KM, Suthar MS (2021) Comprehensive analysis of COVID-19 during pregnancy. Biochem Biophys Res Commun 538:180–186. https://doi.org/10.1016/j.bbrc.2020.12.064

    Article  CAS  PubMed  Google Scholar 

  61. Diriba K, Awulachew E, Getu E (2020) The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res 25(1):39. https://doi.org/10.1186/s40001-020-00439-w

    Article  CAS  PubMed  Google Scholar 

  62. Huntley B, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP (2020) Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol 136(2):303–312. https://doi.org/10.1097/AOG.0000000000004010

    Article  CAS  PubMed  Google Scholar 

  63. National Centers for Disease Control and Prevention (2021) Care for Breastfeeding People: Interim Guidance on Breastfeeding and Breast Milk Feeds in the Context of COVID-19. 2021, June 17. https://www.cdc.gov/coronavirus/2019-ncov/hcp/care-for-breastfeeding-women.html

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Linda Holifield .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Holifield, L. (2022). History and Epidemiology. In: Bergeron, A., Perkins, R., Ingebretson, E., Holifield, L. (eds) Principles in Nursing Practice in the Era of COVID-19. Springer, Cham. https://doi.org/10.1007/978-3-030-94740-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-94740-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-94739-2

  • Online ISBN: 978-3-030-94740-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics